NINLARO Trademark

Trademark Overview

On Wednesday, February 20, 2013, a trademark application was filed for NINLARO with the United States Patent and Trademark Office. The USPTO has given the NINLARO trademark a serial number of 85854620. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, October 12, 2021. This trademark is owned by Millennium Pharmaceuticals, Inc.. The NINLARO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use, namely, for the treatment of hematological malignancies and cancer; pharmaceutical preparations for the treatment of cancer
ninlaro

General Information

Serial Number85854620
Word MarkNINLARO
Filing DateWednesday, February 20, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, October 12, 2021
Registration Number4905454
Registration DateTuesday, February 23, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 16, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use, namely, for the treatment of hematological malignancies and cancer; pharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 27, 2013
Primary Code005
First Use Anywhere DateFriday, December 11, 2015
First Use In Commerce DateFriday, December 11, 2015

Trademark Owner History

Party NameMillennium Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameMillennium Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameMillennium Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Sunday, February 24, 2013NEW APPLICATION ENTERED
Wednesday, February 27, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 5, 2013ASSIGNED TO EXAMINER
Monday, June 10, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 26, 2013NOTICE OF PUBLICATION
Tuesday, July 16, 2013PUBLISHED FOR OPPOSITION
Tuesday, September 10, 2013NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 3, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 3, 2014SOU TEAS EXTENSION RECEIVED
Monday, March 3, 2014SOU EXTENSION 1 FILED
Monday, March 3, 2014SOU EXTENSION 1 GRANTED
Wednesday, March 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 11, 2014SOU TEAS EXTENSION RECEIVED
Wednesday, September 3, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 11, 2014SOU EXTENSION 2 FILED
Wednesday, September 3, 2014SOU EXTENSION 2 GRANTED
Thursday, September 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 17, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, February 17, 2015SOU EXTENSION 3 FILED
Thursday, February 26, 2015SOU EXTENSION 3 GRANTED
Friday, February 27, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 10, 2015SOU TEAS EXTENSION RECEIVED
Monday, August 10, 2015SOU EXTENSION 4 FILED
Monday, August 17, 2015SOU EXTENSION 4 GRANTED
Tuesday, August 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 12, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, January 12, 2016USE AMENDMENT FILED
Monday, January 18, 2016STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 19, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 20, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 23, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Thursday, August 22, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 22, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 23, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, July 1, 2021TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 12, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 12, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, October 12, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, February 23, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, October 30, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 30, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 17, 2025TEAS SECTION 8 & 9 RECEIVED

Related Keywords

ninlaro treatment pharmaceutical cancer preparations malignancies namely human hematological